<DOC>
	<DOCNO>NCT01466283</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarkers patient rhabdomyosarcoma .</brief_summary>
	<brief_title>Biomarkers Patients With Rhabdomyosarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine genome-wide alteration DNA methylation ARMS ERMS . - Determine genome-wide DNA copy number alteration ARMS ERMS . - Determine pathogenic gene pathway integrative genomic analysis . OUTLINE : Genome-wide DNA-methylation analysis ARMS , ERMS , normal human skeletal myoblasts conduct use HELP ( HpaII tiny fragment Enrichment Ligation-mediated PCR ) assay . The methylation status 1.3 million CpGs promoter , gene body , intergenic area analyze . Parallel gene expression analysis do correlate change methylation uncover gene regulate epigenetic alteration alter genomic loss gain . Genes alter genetic epigenetic alteration different set patient select MIGHT ( Multi-dimensional Integration Genomic data Human Tissues ) algorithm uncover new gene potentially involved pathogenesis ARMS ERMS . Gene ontology , pathway , DNA motif analysis algorithm , computational approach use determine biological consequence change . Prioritized set epigenetic genetic alteration validate bisulfite MassArray , FISH , qRT-PCR large number ARMS ERMS sample .</detailed_description>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : 10 ARMS 10 ERMS frozen sample collect COG bank via Cooperative Human Tissue Network ( CHTN ) Human skeletal myoblasts ( ZenBio , Research Triangle Park , NC ) serve control PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood rhabdomyosarcoma</keyword>
</DOC>